Dr Myat Sandi Min
Current positions
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Research interests
I have conducted research on HIV, Viral Hepatitis B and C, sexual and reproductive health, adolescent health, maternal and child health, gender, primary health care and migrant health with a focus on marginalized and underserved populations.
My interests lie in economic and infectious disease modelling, economic evaluation, and health policy research, as well as health system and implementation research, aiming to generate evidence that improves service delivery, strengthens health systems, and informs policy decisions.
Projects and supervisions
Research projects
Modelling and economic evaluation of Hepatitis B virus elimination in Georgia
Description
A 2015 national serosurvey in Georgia estimated chronic HCV prevalence at 5.4% and chronic HBV infection at 2.9%. In response, the country launched an HCV elimination program, achieving a 67%…Managing organisational unit
Bristol Medical SchoolDates
13/01/2025
Cost-effectiveness of Birth Dose Vaccination Strategies in Preventing Mother to Child Transmission of Viral Hepatitis B in Myanmar: Modelling Study
Description
This health economics and policy research project was conducted as the Master's thesis for the Master’s Programme in Health Economics, Policy and Management at Karolinska Institutet in Sweden.Managing organisational unit
Bristol Medical SchoolDates
01/09/2020 to 30/06/2022
Publications
Recent publications
29/03/2024Web Annex D4
Web annex D
Policy brief – Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection
WHO 2024 hepatitis B guidelines
Lancet Gastroenterology and Hepatology
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection
Guidance for country validation of viral hepatitis elimination and path to elimination
Guidance for country validation of viral hepatitis elimination and path to elimination